E3 PreliminaryPreliminaryPEM unclearObservationalPeer-reviewedMachine draft
Increased brain serotonin function in men with chronic fatigue syndrome.
Sharpe, M, Hawton, K, Clements, A et al. · BMJ (Clinical research ed.) · 1997 · DOI
Quick Summary
This 1997 study examined whether people with ME/CFS have differences in serotonin activity in their brains. Serotonin is a chemical messenger that affects mood, sleep, and energy. The researchers found that men with ME/CFS showed increased brain serotonin function compared to healthy controls, which was unexpected since low serotonin is often associated with fatigue and depression.
Why It Matters
This study challenges the simple assumption that ME/CFS results from low serotonin and suggests the neurobiological picture is more complex. Understanding specific brain chemical abnormalities could help develop targeted treatments and explain why standard antidepressants (which increase serotonin) often do not improve ME/CFS symptoms.
Observed Findings
- Male ME/CFS patients demonstrated increased prolactin response to serotonergic challenge compared to healthy control males
- Abnormal serotonergic function was present in the ME/CFS group, contrary to pre-study hypotheses
- The finding suggests altered central serotonergic regulation rather than global serotonin deficiency
Inferred Conclusions
- Serotonergic dysfunction in ME/CFS involves dysregulation rather than simple deficiency
- Increased serotonin function may contribute to or reflect abnormal neurobiological processes in ME/CFS
- Alterations in serotonergic systems may explain treatment resistance to standard serotonergic medications in some ME/CFS patients
Remaining Questions
- Does this finding apply to women with ME/CFS, or is it sex-specific?
- Is the increased serotonin function a primary cause of ME/CFS or a secondary adaptation to other underlying pathology?
- How does this altered serotonergic function relate to other known neurochemical abnormalities in ME/CFS (cytokines, cortisol, etc.)?
- Could this dysregulation be targeted with novel therapeutic approaches designed to restore normal serotonin regulation rather than simply increasing serotonin?
What This Study Does Not Prove
This study does not prove that increased serotonin function causes ME/CFS or that it is the primary mechanism of the illness. It also does not establish whether this finding applies to women with ME/CFS or represents a cause versus a consequence of the disease. Correlation between serotonin activity and ME/CFS status does not indicate causation.
Tags
Symptom:Fatigue
Biomarker:Blood Biomarker
Method Flag:No ControlsSmall SampleSex-Stratified
Metadata
- DOI
- 10.1136/bmj.315.7101.164
- PMID
- 9251547
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 10 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →